Could Getting Very Old Actually Help Protect Us from Cancer? That’s What Stanford’s Research Hints At, By Mrs Vera West and Brian Simpson

A recent Stanford study is turning a long-held assumption on its head: rather than always increasing cancer risk, very advanced age might somehow suppress cancer. If true, it's a provocative twist, a "silver lining" to aging, but also one that brings more questions than clear answers.

What the Scientists Actually Found

In a new experiment, researchers used genetically engineered mice to compare cancer development in young versus very old animals. What they discovered was surprising: the elder mice developed fewer lung tumours, and those tumours that did form were smaller and less aggressive than in their younger counterparts.

They introduced the exact same "cancer-causing" mutations into both groups, yet the older mice fared much better. What's more, when they disabled a set of tumour-suppressor genes (proteins in our body that normally help block cancer), the effect was much weaker in the old mice, especially when it came to a gene called PTEN, which is well-known in cancer biology.

On a molecular level, cancer cells from the old mice still carried "signatures of aging." In other words, aged molecular features didn't just disappear when tumour formation was triggered.

Why This Is Such a Big Deal — and Why It's Surprising

We're used to thinking: more age = more mutations = more cancer. Every time our cells divide, there's a small chance of mutation, so over decades, the risk piles up. That model holds for a large part of life: cancer risk rises in mid to late adulthood.

But here's the catch: in human populations, cancer rates don't simply shoot upward forever. After a certain age (~85+), the incidence of cancer appears to level off or even drop. Until now, scientists weren't sure if that was because older people are diagnosed less, or because maybe something biological is working in their favour. The Stanford mice study suggests it's not just a statistical illusion, there might be real protective mechanisms at work.

How Aging Might Actually Suppress Cancer — Theories and Mechanisms

The researchers and commentators suggest several possible explanations behind this surprising effect:

1.Tissue environment changes — As we age, the "soil" in our organs changes. Older tissues might become less permissive for tumour growth.

2.Epigenetic reprogramming — Chemical tags on DNA (like methyl groups) change with age. Some of these age-related changes might actually hamper cancer progression.

3.Tumour suppressors lose impact with age — The fact that disabling PTEN had a weaker effect in old mice suggests age alters how these crucial "guard-genes" function.

4.Age signature persists in cancer cells — Very interestingly, even rapidly dividing cancer cells in old mice kept many molecular "signatures of age." That means the aging program isn't erased during malignant transformation.

But There Are Big Cautions — This Isn't a Free Pass

While the results are hopeful, they don't mean aging is a cure for cancer — far from it:

It's a mouse model: The study was done in genetically engineered mice, not humans. Biology can be very different between species.

Not all cancers are the same: This research focused on lung cancer in a very specific model. Other types of cancer, or different genetic drivers, might not behave the same way.

Old doesn't mean immune: Lower incidence in very old mice doesn't guarantee immunity. Aging brings its own risks, frailty, immune decline, and other diseases.

Therapeutic translation is tricky: Even if aging mechanisms could be "borrowed" for therapy, intentionally inducing age-like changes raises its own dangers.

Conflicting research: Other studies show that the aging immune system can promote cancer, especially through inflammation.

So Why This Matters — And What Could It Lead To

If these findings hold up, they could reshape how scientists think about cancer treatment and prevention in older people. For example:

Better cancer models: Many preclinical cancer experiments use young animals. This research suggests using aged models might yield more accurate insights.

New therapeutic strategies: Understanding how aging suppresses tumours could lead to drugs that mimic those "protective" aged states.

Personalised cancer treatment: If tumour suppressor genes work differently depending on age, cancer therapies might need to be tailored by patient age.

Rethinking aging: The notion that aging is purely "bad" for cancer risk could be oversimplified. Some aspects of aging might be harnessed for good.

Final Thoughts

The Stanford study is a fascinating and hopeful development, a potential paradigm shift in how we understand aging and cancer. But it's not a magic bullet. The idea that aging could suppress cancer in some contexts is both scientifically intriguing and clinically promising, yet there's a long way to go from findings in old mice to safe and effective treatments in humans. Science is teasing out the complexity of aging, and this might be one of those rare cases where getting older comes with unexpected advantages, if we learn how to use them wisely.

https://scitechdaily.com/stanford-scientists-discover-aging-may-suppress-cancer-not-fuel-it/